Home > Research > Publications & Outputs > Progress in Active Ingredient Formulations

Electronic data

  • Progress in Active Ingredient Formulations_accepted

    Accepted author manuscript, 877 KB, PDF document

    Available under license: CC BY-NC-ND: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

  • 211-225-jmtr-jul19

    Final published version, 527 KB, PDF document

    Available under license: CC BY-NC-ND: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

Links

Text available via DOI:

View graph of relations

Progress in Active Ingredient Formulations: Towards smart stimuli-responsive formulations

Research output: Contribution to Journal/MagazineLiterature reviewpeer-review

Published

Standard

Progress in Active Ingredient Formulations: Towards smart stimuli-responsive formulations. / Ashton, Mark; Hardy, John.
In: Johnson Matthey Technology Review, Vol. 63, No. 3, 09.07.2019, p. 211-225.

Research output: Contribution to Journal/MagazineLiterature reviewpeer-review

Harvard

APA

Vancouver

Ashton M, Hardy J. Progress in Active Ingredient Formulations: Towards smart stimuli-responsive formulations. Johnson Matthey Technology Review. 2019 Jul 9;63(3):211-225. Epub 2019 May 24. doi: 10.1595/205651319X15585277727868

Author

Ashton, Mark ; Hardy, John. / Progress in Active Ingredient Formulations : Towards smart stimuli-responsive formulations. In: Johnson Matthey Technology Review. 2019 ; Vol. 63, No. 3. pp. 211-225.

Bibtex

@article{be0a09882ebf4f0d8bddda28b0de1e72,
title = "Progress in Active Ingredient Formulations: Towards smart stimuli-responsive formulations",
abstract = "The formulation and delivery of the biologically active ingredients (AIs) (e.g. agrochemicals and pharmaceuticals, active pharmaceutical ingredients (APIs)) is an inherently interdisciplinary area of research and development. In this short review we discuss the evolution of AI/API delivery systems towards smart stimuli-responsive formulations with precisely controlled delivery for specific applications (we also highlight a few examples of such systems using AIs from Johnson Matthey{\textquoteright}s Controlled Substance and API Portfolio).",
keywords = "pharmaceutical sciences, drug delivery, Stimuli-Responsive Materials",
author = "Mark Ashton and John Hardy",
year = "2019",
month = jul,
day = "9",
doi = "10.1595/205651319X15585277727868",
language = "English",
volume = "63",
pages = "211--225",
journal = "Johnson Matthey Technology Review",
number = "3",

}

RIS

TY - JOUR

T1 - Progress in Active Ingredient Formulations

T2 - Towards smart stimuli-responsive formulations

AU - Ashton, Mark

AU - Hardy, John

PY - 2019/7/9

Y1 - 2019/7/9

N2 - The formulation and delivery of the biologically active ingredients (AIs) (e.g. agrochemicals and pharmaceuticals, active pharmaceutical ingredients (APIs)) is an inherently interdisciplinary area of research and development. In this short review we discuss the evolution of AI/API delivery systems towards smart stimuli-responsive formulations with precisely controlled delivery for specific applications (we also highlight a few examples of such systems using AIs from Johnson Matthey’s Controlled Substance and API Portfolio).

AB - The formulation and delivery of the biologically active ingredients (AIs) (e.g. agrochemicals and pharmaceuticals, active pharmaceutical ingredients (APIs)) is an inherently interdisciplinary area of research and development. In this short review we discuss the evolution of AI/API delivery systems towards smart stimuli-responsive formulations with precisely controlled delivery for specific applications (we also highlight a few examples of such systems using AIs from Johnson Matthey’s Controlled Substance and API Portfolio).

KW - pharmaceutical sciences

KW - drug delivery

KW - Stimuli-Responsive Materials

U2 - 10.1595/205651319X15585277727868

DO - 10.1595/205651319X15585277727868

M3 - Literature review

VL - 63

SP - 211

EP - 225

JO - Johnson Matthey Technology Review

JF - Johnson Matthey Technology Review

IS - 3

ER -